Spots Global Cancer Trial Database for head & neck cancer
Every month we try and update this database with for head & neck cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| DRIHNC - Dehydration Reduction in Head & Neck Cancer | NCT03799380 | Dehydration Head & Neck Can... Esophageal Canc... | Gatorade G2 Standard of car... | 18 Years - | Case Comprehensive Cancer Center | |
| Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA | NCT02211027 | Head and Neck S... | Semi-allogenic ... | 18 Years - | University of Pittsburgh | |
| PCA062 in pCAD-positive Tumors. | NCT02375958 | Triple Negative... Head & Neck Can... Esophageal Canc... | PCA062 | 18 Years - | Novartis | |
| PCA062 in pCAD-positive Tumors. | NCT02375958 | Triple Negative... Head & Neck Can... Esophageal Canc... | PCA062 | 18 Years - | Novartis | |
| Perioperative Analgesia on Postoperative Opioid Usage and Pain Control in H&N Cancer Surgery | NCT04176419 | Postoperative P... Opioid Consumpt... | Ketamine Placebo Ketamin... Lidocaine Placebo Lidocai... Acetaminophen Placebo Acetami... Gabapentin Placebo Gabapen... Celecoxib Placebo Celecox... | 18 Years - | Case Comprehensive Cancer Center | |
| Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy | NCT03712397 | Head & Neck Can... | nanoliposomal i... | 20 Years - | National Health Research Institutes, Taiwan | |
| Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors | NCT03552406 | Solid Tumor | ISU104 Cetuximab | 19 Years - | ISU Abxis Co., Ltd. | |
| Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients | NCT00629265 | Dysphagia | Neurotech NT200... | 21 Years - | Boston Medical Center | |
| Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors | NCT03065062 | Lung Cancer Squ... Solid Tumors Head & Neck Can... Pancreatic Canc... | Palbociclib Gedatolisib | 18 Years - | Dana-Farber Cancer Institute | |
| Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy | NCT01367990 | Alopecia Radiodermatitis | Norepinephrine | 18 Years - | ProCertus BioPharm, Inc | |
| Weekly Nanoparticle Albumin-Bound Paclitaxel (Abraxane) + Weekly Cetuximab + Radiation Therapy (IMRT, Intensity-Modulated Radiation Therapy) in Patients With Stage III-IVB Head and Neck Squamous Cell Carcinoma (HNSCC) | NCT00736619 | HEAD & NECK Can... | Cetuximab, IMRT... | 18 Years - 100 Years | Memorial Sloan Kettering Cancer Center | |
| RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer | NCT00935961 | HEAD & NECK Can... | RAD001 + doceta... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer | NCT00670553 | Prostate Cancer Head & Neck Can... Esophageal Canc... | panobinostat | 18 Years - | Novartis | |
| A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis | NCT00565721 | High-grade Glio... Lung Cancer Head & Neck Can... Sarcoma Melanoma | Fluciclatide In... | 18 Years - | GE Healthcare | |
| Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors | NCT03552406 | Solid Tumor | ISU104 Cetuximab | 19 Years - | ISU Abxis Co., Ltd. | |
| Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | NCT01434342 | Lung Cancer Tobacco Use Dis... Breast Cancer Colorectal Canc... Prostate Cancer | Nicotine Replac... | 18 Years - | Wake Forest University Health Sciences | |
| Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors | NCT03065062 | Lung Cancer Squ... Solid Tumors Head & Neck Can... Pancreatic Canc... | Palbociclib Gedatolisib | 18 Years - | Dana-Farber Cancer Institute | |
| RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer | NCT00935961 | HEAD & NECK Can... | RAD001 + doceta... | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
